Ad-HGF Treatment for Myocardial Infarction

A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT02844283

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 1/2
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02844283
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
Not reported
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02844283. Randomized; quadruple masking; primary purpose treatment. Start 2016-11 (registry gives no type); primary completion 2018-07 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Ad-HGF Treatment for Myocardial Infarction
Intervention (Drug)
Ad-HGF
Intervention (Other)
0.9% NaCl
Lead sponsor
The First Affiliated Hospital with Nanjing Medical University (class: other)

Record details

Record id
cardio:ct-nct02844283
Content hash
dcb1dd88c4ce2e16b49a7aef121f0160410c7865f5e45022e8237f27aac9039d